Targeted conformal radiotherapy of disseminated cancers, using the alpha-particle emitting radionuclides astatine-211, bismuth-213 and actinium-225

Project Information

Alpha cancer therapy

Grant agreement ID: 272348

Project closed

Start date 1 April 2012

End date 1 November 2014

Funded under

• Specific programme "People" implementing the Seventh Framework Programme of the European Community for research, technological development and demonstration activities (2007 to 2013)

Total cost € 259 065,00

EU contribution € 259 065,00

Coordinated by

GOETEBORGS UNIVERSITET
Sweden